A detailed history of Wells Trecaso Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wells Trecaso Financial Group, LLC holds 1,818 shares of NVO stock, worth $158,838. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,818
Previous 1,758 3.41%
Holding current value
$158,838
Previous $250,000 13.6%
% of portfolio
0.07%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$119.07 - $145.42 $7,144 - $8,725
60 Added 3.41%
1,818 $216,000
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $736 - $881
-6 Reduced 0.34%
1,758 $250,000
Q1 2024

Apr 24, 2024

BUY
$102.11 - $135.92 $180,122 - $239,762
1,764 New
1,764 $226,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wells Trecaso Financial Group, LLC Portfolio

Follow Wells Trecaso Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Trecaso Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wells Trecaso Financial Group, LLC with notifications on news.